MARSHALL WACE, LLP - NEVRO CORP ownership

NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 182 filers reported holding NEVRO CORP in Q2 2022. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of NEVRO CORP
ValueSharesWeighting
Q2 2023$809,424
-79.5%
31,842
-70.9%
0.00%
-75.0%
Q1 2023$3,954,123
-2.1%
109,381
+7.3%
0.01%
-11.1%
Q4 2022$4,037,695
-53.5%
101,962
-45.3%
0.01%
-52.6%
Q3 2022$8,680,000
-70.8%
186,311
-72.5%
0.02%
-68.9%
Q2 2022$29,676,000
-10.2%
677,090
+48.3%
0.06%
-3.2%
Q1 2022$33,033,000
+153.4%
456,706
+184.0%
0.06%
+162.5%
Q4 2021$13,036,000
+433.0%
160,792
+664.9%
0.02%
+140.0%
Q3 2021$2,446,000
+46.7%
21,020
+118.3%
0.01%
+11.1%
Q4 2020$1,667,000
+121.7%
9,630
-20.1%
0.01%
+125.0%
Q1 2019$752,000
-25.7%
12,048
-53.7%
0.00%
-60.0%
Q4 2018$1,012,000
-70.4%
26,043
-56.6%
0.01%
-33.3%
Q3 2018$3,422,000
+683.1%
60,036
+916.5%
0.02%
-21.1%
Q2 2017$437,000
-93.4%
5,906
-90.6%
0.02%
-59.6%
Q3 2016$6,591,000
+179.5%
63,140
+28.3%
0.05%
+51.6%
Q1 2015$2,358,000
+130.0%
49,194
+85.6%
0.03%
+121.4%
Q4 2014$1,025,00026,5020.01%
Other shareholders
NEVRO CORP shareholders Q2 2022
NameSharesValueWeighting ↓
Tiger Eye Capital LLC 239,122$41,392,0008.25%
Integral Health Asset Management, LLC 88,000$15,233,0004.53%
Iron Triangle Partners LP 168,761$29,213,0003.79%
Eos Focused Equity Management, L.P. 14,002$2,424,0002.37%
PFM Health Sciences, LP 311,940$53,997,0001.90%
Perceptive Advisors 977,565$169,217,0001.82%
Rock Springs Capital Management LP 395,000$68,375,0001.45%
Lisanti Capital Growth, LLC 54,302$9,400,0001.30%
HealthCor Management, L.P. 156,046$27,012,0001.04%
FRED ALGER MANAGEMENT, LLC 2,136,612$369,848,0000.96%
View complete list of NEVRO CORP shareholders